share_log

Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target

Benzinga ·  Aug 8, 2023 10:09

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment